Related Experiment Video
Updated: Jul 24, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Benefits of Frequent HIV Testing in the THRIVE Demonstration Project: United States, 2015-2020
Anne A Kimball1, Weiming Zhu1, Lei Yu1
1Anne A. Kimball, Weiming Zhu, Mary R. Tanner, Kashif Iqbal, Kenneth L. Dominguez, Kevin P. Delaney, and Karen W. Hoover are with the Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA. Lei Yu is with the DLH Corporation, Atlanta. Aparna Shankar is with the New York City Department of Health and Mental Hygiene, New York, NY. Kate Drezner is with the District of Columbia Department of Health, Washington, DC. Karen Musgrove is with Birmingham AIDS Outreach, Birmingham, AL. Eric Mayes is with the Virginia Department of Health, Richmond. William T. Robinson is with the Louisiana Office of Public Health and Louisiana State University Health Sciences Center, New Orleans. Christina Schumacher is with the Center for Child and Community Health Research, Johns Hopkins School of Medicine, Baltimore, MD.
Abstract:
Objectives. To describe HIV testing among clients in the Targeted Highly Effective Interventions to Reverse the HIV Epidemic (THRIVE) demonstration project and evaluate testing frequency. Methods. We identified factors associated with an average testing frequency of 180 days or less compared with more than 180 days using adjusted Poisson regression models. We performed the Kaplan-Meier survival analysis to compare time to diagnosis by testing frequency. Results. Among 5710 clients with 2 or more tests and no preexposure prophylaxis (PrEP) prescription, 42.4% were tested frequently. Black/African American clients were 21% less likely and Hispanic/Latino clients were 18% less likely to be tested frequently than were White clients. Among 71 Black/African American and Hispanic/Latino cisgender men who have sex with men and transgender women with HIV diagnoses, those with frequent testing had a median time to diagnosis of 137 days, with a diagnostic testing yield of 1.5% compared with those tested less frequently, with 559 days and 0.8% yield. Conclusions. HIV testing at least every 6 months resulted in earlier HIV diagnosis and was efficient. Persons in communities with high rates of HIV who are not on PrEP can benefit from frequent testing, and collaborative community approaches may help reduce disparities. (Am J Public Health. 2023;113(9):1019-1027. https://doi.org/10.2105/AJPH.2023.307341).
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Preventive Healthcare Services
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Clinical Trials: Overview
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...

